Impulse control disorders in Parkinson's disease
Abstract
Impulse control disorders (ICDs), a group of complex behavioral disorders, occur more commonly in Parkinson's disease (PD) patients than in the general population, with a reported prevalence up to 13.6% in some studies. The most common ICDs reported are pathological gambling (PG), hypersexuality (HS), compulsive shopping and compulsive eating. More than a quarter of the patients with ICDs have 2 or more behavioral addictions. These abnormal behaviors impair activities of daily living and have a negative impact on quality of life of patients and their families. As with many other non motor symptoms in PD, ICDs are frequently under-reported by patients and caregivers and may be under-recognized by the treating physicians. Treatment with dopamine agonists (DA) is the main risk factor for developing ICDs, and stimulation of mesolimbic D3 receptors by DA is thought to underlie their development. The DA effect seems to be a class effect and not specific for any DA. Levodopa can also induce ICDs but much less so than the DAs. The management of ICDs in PD is complex. Modifications in dopaminergic drug treatment are frequently necessary. In some cases alternative therapies such as atypical antipsychotics, antidepressants or deep brain stimulation if motor symptoms become incapacitating after adjustment of dopamine replacement therapy should be considered.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Administering specific dopamine agonists can activate previously non-existent behaviors such as compulsive gambling, compulsive eating, hypersexuality, and compulsive shopping.
“Thus, administering specific dopamine agonists can activate previously non-existent behaviors, such as compulsive gambling, compulsive eating, hypersexuality, and compulsive shopping (18–21).”
From Cell-phone addiction: a review (2016) · cites this paper as [21]
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,841 · see citing works
Impulse Control Disorders in Parkinson Disease
Weintraub, D. A., Koester, J., Potenza, M. N., Siderowf, A. D., Stacy, M. A., Voon, V., Whetteckey, J., Wunderlich, G. R., & Lang, A. E. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.65 · Cited by 1,493 · see citing works
Kaplan, H. I., & Sadock, B. J. (1989) · International Clinical Psychopharmacology · doi:10.1097/00004850-198907000-00008 · Cited by 855 · see citing works
Compulsive buying: a report of 20 cases.
McElroy, S. L., Keck, P. E., Pope, H. G., Smith, J., & Strakowski, S. M. (1994) · PubMed · Cited by 646 · see citing works
Giovannoni, G. (2000) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.68.4.423 · Cited by 587 · see citing works
Pathological Gambling Caused by Drugs Used to Treat Parkinson Disease
Dodd, M. L., Klos, K. J., Bower, J. H., Geda, Y. E., Josephs, K. A., & Ahlskog, J. E. (2005) · Archives of Neurology · doi:10.1001/archneur.62.9.noc50009 · Cited by 563 · see citing works
Validation of the questionnaire for impulsive‐compulsive disorders in Parkinson's disease
Weintraub, D., Hoops, S., Shea, J. A., Lyons, K. E., Pahwa, R., Driver‐Dunckley, E. D., Adler, C. H., Potenza, M. N., Miyasaki, J., Siderowf, A. D., et al. (2009) · Movement Disorders · doi:10.1002/mds.22571 · Cited by 528 · see citing works
Steeves, T. D. L., Miyasaki, J., Zurowski, M., Lang, A. E., Pellecchia, G., Van Eimeren, T., Rusjan, P., Houle, S., & Strafella, A. P. (2009) · Brain · doi:10.1093/brain/awp054 · Cited by 502 · see citing works
Punding in Parkinson's disease: Its relation to the dopamine dysregulation syndrome
Evans, A. H., Katzenschlager, R., Paviour, D. C., O’Sullivan, J. D., Appel, S., Lawrence, A. D., & Lees, A. J. (2004) · Movement Disorders · doi:10.1002/mds.20045 · Cited by 474 · see citing works
Prevalence of repetitive and reward-seeking behaviors in Parkinson disease
Voon, V., Hassan, K. T., Zurowski, M., de Souza, M., Thomsen, T. R., Fox, S. H., Lang, A. E., & Miyasaki, J. M. (2006) · Neurology · doi:10.1212/01.wnl.0000238503.20816.13 · Cited by 417 · see citing works
Punding in Parkinson's disease: Its relation to the dopamine dysregulation syndrome
Evans, A., Katzenschlager, R., Paviour, D. C., Appel‐Cresswell, S., Lawrence, A., & Lees, A. J. (2004) · UCL Discovery (University College London) · Cited by 401 · see citing works
Impulse control disorders in parkinson disease: A multicenter case–control study
Voon, V., Sohr, M., Lang, A. E., Potenza, M. N., Siderowf, A. D., Whetteckey, J., Weintraub, D. A., Wunderlich, G. R., & Stacy, M. A. (2011) · Annals of Neurology · doi:10.1002/ana.22356 · Cited by 400 · see citing works
Medication-Related Impulse Control and Repetitive Behaviors in Parkinson Disease
Voon, V., & Fox, S. H. (2007) · Archives of Neurology · doi:10.1001/archneur.64.8.1089 · Cited by 397 · see citing works
Dopamine Agonist Withdrawal Syndrome in Parkinson Disease
Rabinak, C. A., & Nirenberg, M. J. (2010) · Archives of Neurology · doi:10.1001/archneurol.2009.294 · Cited by 347 · see citing works
Pathological gambling associated with dopamine agonist therapy in Parkinson’s disease
Driver‐Dunckley, E. D., Samanta, J., & Stacy, M. A. (2003) · Neurology · doi:10.1212/01.wnl.0000076478.45005.ec · Cited by 317 · see citing works
Klos, K. J., Bower, J. H., Josephs, K. A., Matsumoto, J. Y., & Ahlskog, J. E. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2005.06.005 · Cited by 283 · see citing works
Compulsive eating and weight gain related to dopamine agonist use
Nirenberg, M. J., & Waters, C. (2005) · Movement Disorders · doi:10.1002/mds.20757 · Cited by 261 · see citing works
Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation
Ardouin, C., Voon, V., Worbe, Y., Abouazar, N., Czernecki, V., Hosseini, H., Pélissolo, A., Moro, E., Lhommée, E., Lang, A. E., et al. (2006) · Movement Disorders · doi:10.1002/mds.21098 · Cited by 257 · see citing works
Lim, S., O’Sullivan, S. S., Kotschet, K. E., Gallagher, D. A., Lacey, C. J., Lawrence, A. D., Lees, A. J., O'Sullivan, D. J., Peppard, R. F., Rodrigues, J. P., et al. (2009) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2008.12.010 · Cited by 240 · see citing works
Long‐term follow‐up of impulse control disorders in Parkinson's disease
Mamikonyan, E., Siderowf, A. D., Duda, J. E., Potenza, M. N., Horn, S. S., Stern, M. B., & Weintraub, D. A. (2007) · Movement Disorders · doi:10.1002/mds.21770 · Cited by 234 · see citing works
Pathological gambling in Parkinson disease is reduced by amantadine
Thomas, A., Bonanni, L., Gambi, F., Iorio, A. D., & ONOFRJ, M. C. (2010) · Annals of Neurology · doi:10.1002/ana.22029 · Cited by 234 · see citing works
Cornelius, J. R., Tippmann‐Peikert, M., Slocumb, N. L., Frerichs, C. F., & Silber, M. H. (2010) · SLEEP · doi:10.1093/sleep/33.1.81 · Cited by 199 · see citing works
Impulse control disorders in Parkinson's disease
Voon, V., Mehta, A. R., & Hallett, M. (2011) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3283489687 · Cited by 195 · see citing works
Prevalence of pathological gambling in patients with Parkinson's disease
Avanzi, M., Baratti, M., Cabrini, S., Uber, E., Brighetti, G., & Bonfà, F. (2006) · Movement Disorders · doi:10.1002/mds.21072 · Cited by 158 · see citing works
Association of DRD3 and GRIN2B with impulse control and related behaviors in Parkinson's disease
Lee, J., Lee, E. K., Park, S. S., Lim, J., Kim, H. J., Kim, J. S., & Jeon, B. S. (2009) · Movement Disorders · doi:10.1002/mds.22678 · Cited by 155 · see citing works
Lee, J., Jeon, B. S., Kim, H., & Park, S. S. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.08.009 · Cited by 85 · see citing works
Zonisamide in managing impulse control disorders in Parkinson’s disease
Bermejo, P. E., Ruíz-Huete, C., & Anciones, B. (2010) · Journal of Neurology · doi:10.1007/s00415-010-5603-7 · Cited by 70 · see citing works
Impulse-Control Disorders in Parkinson's Disease
Ferrara, J. M., & Stacy, M. A. (2008) · CNS Spectrums · doi:10.1017/s1092852900013778 · Cited by 57 · see citing works
Disturbed sensorimotor processing during control of precision grip in patients with writer's cramp
Serrien, D. J., Burgunder, J., & Wiesendanger, M. (2000) · Movement Disorders · doi:10.1002/1531-8257(200009)15:5 · Cited by 52 · see citing works
Clinical aspects of impulsive compulsive behaviours in Parkinson's disease
Djamshidian, A., Averbeck, B. B., Lees, A. J., & O’Sullivan, S. S. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.07.031 · Cited by 46 · see citing works
Flagged first, then by citations
1 of the 31 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Cell-phone addiction: a review
De-Sola Gutiérrez, J., Rodríguez de Fonseca, F., & Rubio, G. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00175 · Cited by 722 · see citing works
Online Porn Addiction: What We Know and What We Don’t—A Systematic Review
de Alarcón, R., de la Iglesia, J., Casado‐Espada, N. M., & Montejo, A. L. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8010091 · Cited by 267 · see citing works
Neuroimaging in Parkinson disease: from research setting to clinical practice
Politis, M. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.205 · Cited by 247 · see citing works
Biomarkers in Parkinson’s disease (recent update)
Sharma, S. K., Moon, C. S., Khogali, A., Haidous, A., Chabenne, A., Ojo, C., Jelebinkov, M., Kurdi, Y., & Ebadi, M. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.06.005 · Cited by 242 · see citing works
Levodopa in the Treatment of Parkinson's Disease: Current Status and New Developments
Salat, D., & TOLOSA, E. S. (2013) · Journal of Parkinson s Disease · doi:10.3233/jpd-130186 · Cited by 243 · see citing works
Self-citationBehavioral Addictions: An Overview
Karim, R., & Chaudhri, P. (2012) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2012.662859 · Cited by 239 · see citing works
Clinical and Pathological Features of Parkinson’s Disease
Schneider, S. A., & Obeso, J. A. (2014) · Current topics in behavioral neurosciences · doi:10.1007/7854_2014_317 · Cited by 131 · see citing works
Pearson‐Fuhrhop, K. M., Minton, B. R., Acevedo, D., Shahbaba, B., & Cramer, S. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061197 · Cited by 119 · see citing works
Nonmotor Symptoms in Parkinson's Disease
Sung, V., & Nicholas, A. P. (2013) · Neurologic Clinics · doi:10.1016/j.ncl.2013.04.013 · Cited by 117 · see citing works
Mechanisms of Body Weight Fluctuations in Parkinson’s Disease
Kistner, A., Lhommée, E., & Krack, P. (2014) · Frontiers in Neurology · doi:10.3389/fneur.2014.00084 · Cited by 114 · see citing works
Behavioural addiction—A rising tide?
Chamberlain, S. R., Löchner, C., Stein, D. J., Goudriaan, A. E., van Holst, R. J., Zohar, J., & Grant, J. E. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.08.013 · Cited by 113 · see citing works
DSM-5 and the Decision Not to Include Sex, Shopping or Stealing as Addictions
Piquet-Pessôa, M., Ferreira, G. M., Melca, I., & Fontenelle, L. F. (2014) · Current Addiction Report · doi:10.1007/s40429-014-0027-6 · Cited by 96 · see citing works
Abidin, S. Z., Tan, E. L., Chan, S. C., Jaafar, A., Lee, A. X., Hamid, M. H. N. A., Murad, N. A. A., Razy, N. F. P., Azmin, S., Ahmad‐Annuar, A., et al. (2015) · BMC Neurology · doi:10.1186/s12883-015-0316-2 · Cited by 87 · see citing works
Pettorruso, M., Martinotti, G., Fasano, A. A., Loria, G., Nicola, M. D., Risio, L. D., Ricciardi, L., Conte, G., Janiri, L., & Bentivoglio, A. R. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.12.013 · Cited by 86 · see citing works
Sexuality in patients with Parkinson's disease, Alzheimer's disease, and other dementias
Bronner, G., Aharon‐Peretz, J., & Hassin‐Baer, S. (2015) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63247-0.00017-1 · Cited by 55 · see citing works
Santin, M. D. N., Voulleminot, P., Vrillon, A., Hainque, É., Béreau, M., Lagha‐Boukbiza, O., Wirth, T., Montaut, S., Bardinet, É., Kyheng, M., et al. (2020) · Movement Disorders · doi:10.1002/mds.28320 · Cited by 55 · see citing works
Neurogenetics and Epigenetics in Impulsive Behaviour: Impact on Reward Circuitry
Archer, T., & Blum, K. (2012) · Journal of Genetic Syndromes & Gene Therapy · doi:10.4172/2157-7412.1000115 · Cited by 54 · see citing works
Screen use during food consumption: Does it cause increased food intake? A systematic review
Tabares, M. T., Moreno, L. A., Cervantes, V. G. A., León-Landa, E. H., & López-Espinoza, A. (2022) · Appetite · doi:10.1016/j.appet.2022.105928 · Cited by 51 · see citing works
Impulse-Control Disorders in Parkinson’s Disease: A Meta-Analysis and Review of Case–Control Studies
Molde, H., Moussavi, Y., Kopperud, S. T., Erga, A. H., Hansen, A. L., & Pallesen, S. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00330 · Cited by 51 · see citing works
Neuropsychiatric symptoms in untreated Parkinson’s disease
Szatmári, S., Illigens, B. M. W., Siepmann, T., Pintér, A., Takáts, A., & Bereczki, D. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s130997 · Cited by 47 · see citing works
Houéto, J., Magnard, R., Dalley, J. W., Belin, D., & Carnicella, S. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00091 · Cited by 45 · see citing works
Attenuated neural response to gamble outcomes in drug-naive patients with Parkinson’s disease
van der Vegt, J. P. M., Hulme, O. J., Zittel, S., Madsen, K. H., Weiß, M., Buhmann, C., Bloem, B. R., Münchau, A. M., & Siebner, H. R. (2013) · Brain · doi:10.1093/brain/awt027 · Cited by 44 · see citing works
Impact of Neuropsychiatric Symptoms on the Quality of Life of Subjects with Parkinson’s Disease
Alvarado‐Bolaños, A., Cervantes‐Arriaga, A., Rodríguez‐Violante, M., Llorens‐Arenas, R., Calderón‐Fajardo, H., Millán-Cepeda, R., Leal-Ortega, R., Estrada-Bellmann, I. E., & Zúñiga‐Ramírez, C. (2015) · Journal of Parkinson s Disease · doi:10.3233/jpd-150597 · Cited by 41 · see citing works
Okun, M. S., & Weintraub, D. A. (2013) · Movement Disorders · doi:10.1002/mds.25735 · Cited by 34 · see citing works
Neural and behavioral substrates of subtypes of Parkinson’s disease
Moustafa, A. A., & Poletti, M. (2013) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2013.00117 · Cited by 34 · see citing works
Therapeutic doses of buspirone block D3 receptors in the living primate brain
Kim, S. W., Fowler, J. S., Skolnick, P., Muench, L., Kang, Y., Shea, C. E., Logan, J., Kim, D., Carter, P., King, P. T., et al. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000194 · Cited by 33 · see citing works
Available and future treatments for atypical parkinsonism. A systematic review
Moretti, D. V. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13068 · Cited by 31 · see citing works
Maniaci, G., Picone, F., Dimarco, T., Lipari, A., Brancato, A., & Cannizzaro, C. (2015) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-015-9550-5 · Cited by 28 · see citing works
Parkinson's Disease and Its Management: Part 4: Treatment of Motor Complications.
DeMaagd, G. A., & Philip, A. (2015) · PubMed Central · Cited by 23 · see citing works
Pirritano, D., Plastino, M., Bosco, D., Gallelli, L., Siniscalchi, A., & Sarro, G. D. (2014) · BioMed Research International · doi:10.1155/2014/728038 · Cited by 22 · see citing works
DeMaagd, G. A., & Philip, A. (2015) · PubMed Central · Cited by 21 · see citing works
Modestino, E. J., Blum, K., Dennen, C. A., Downs, B. W., Bagchi, D., Llanos-Gomez, L., Elman, I., Baron, D. A., Thanos, P. K., Badgaiyan, R. D., et al. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12121946 · Cited by 17 · see citing works
Impulse control disorders in Parkinson’s disease: Predominant role of psychological determinants
Garlovsky, J. K., Simpson, J., Grünewald, R. A., & Overton, P. G. (2016) · Psychology and Health · doi:10.1080/08870446.2016.1218879 · Cited by 17 · see citing works
Jeon, N., & Bortolato, M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0227128 · Cited by 14 · see citing works
Moretti, D. V., Binetti, G. G., Zanetti, O. O., & Frisoni, G. B. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s64015 · Cited by 14 · see citing works
Impulse Control Disorders in Parkinson’s Disease: Background and Update On Prevention and Management
Leeman, R. F., Billingsley, B., & Potenza, M. N. (2012) · Neurodegenerative Disease Management · doi:10.2217/nmt.12.35 · Cited by 14 · see citing works
Clozapine use for refractory impulse control disorders in Parkinson’s disease: a case report
Bonfils, N. A., Benyamina, A., Aubin, H., & Luquiens, A. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4048-1 · Cited by 13 · see citing works
Convergent dysregulation of frontal cortical cognitive and reward systems in eating disorders
Kream, R. M. (2013) · Medical Science Monitor · doi:10.12659/msm.889133 · Cited by 13 · see citing works
Behavioral and Neurophysiological Effects of Transdermal Rotigotine in Atypical Parkinsonism
Moretti, D. V., Binetti, G. G., Zanetti, O. O., & Frisoni, G. B. (2014) · Frontiers in Neurology · doi:10.3389/fneur.2014.00085 · Cited by 12 · see citing works
Ludwiczak, A., Jahanshahi, M., & Osman, M. (2014) · Neurodegenerative Disease Management · doi:10.2217/nmt.14.23 · Cited by 11 · see citing works
Fedosova, A., Titova, N., Григорьевна, К. З., Shipilova, N. N., Катунина, Е. А., & Климов, Е. А. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11121321 · Cited by 10 · see citing works
Behavioral disorders in Parkinson disease: current view
Jellinger, K. (2024) · Journal of neural transmission · doi:10.1007/s00702-024-02846-3 · Cited by 10 · see citing works
Floris, G., Scheggi, S., Pes, R., & Bortolato, M. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.01.020 · Cited by 8 · see citing works
Moretti, D. V., Binetti, G. G., Zanetti, O. O., & Frisoni, G. B. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.05.028 · Cited by 9 · see citing works
Nymphomania Associated With Childhood Sexual Abuse: A Case Report
Mujawar, S., Chaudhury, S., Saldanha, D., & Jafar, A. K. (2021) · Journal of Psychosexual Health · doi:10.1177/26318318211013615 · Cited by 8 · see citing works
Schmitt, E., Debu, B. H. G., Castrioto, A., Kistner, A., Fraix, V., Bouvard, M. A., & Moro, E. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1242484 · Cited by 7 · see citing works
Sex, drugs and Parkinson’s disease
Ushe, M., & Perlmutter, J. S. (2013) · Brain · doi:10.1093/brain/awt022 · Cited by 5 · see citing works
Neuropsychological aspects of impulse control disorders in Parkinson’s disease
Scanferla, L., & Djamshidian, A. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1768251 · Cited by 3 · see citing works
Belief in omens and superstitions among patients with chronic neurological disorders
Mameniškienė, R., Kizlaitienė, R., Lokominienė, R. K., & Puteikis, K. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1331254 · Cited by 3 · see citing works
Are there treatments for atypical parkinsonism? An update on actual options
Moretti, D. V. (2015) · Reviews in the Neurosciences · doi:10.1515/revneuro-2015-0008 · Cited by 3 · see citing works
Arts, K. (2014) · Tijdschrift voor Neuropsychiatrie en Gedragsneurologie · doi:10.1007/s40533-014-0003-4 · Cited by 2 · see citing works
Schedlich‐Teufer, C., Jost, S. T., Krack, P., Witt, K., Weintraub, D. A., Baldermann, J. C., Sommerauer, M., Amstutz, D., van Eimeren, T., Dafsari, H. S., et al. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-202375 · Cited by 2 · see citing works
Eckert, V. V. S., Wette, S. A., & Stüttgen, M. C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20123098 · Cited by 2 · see citing works
Pharmacotherapy for Behavioral Addictions
Grant, J. E., & Chamberlain, S. R. (2016) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-016-0065-6 · Cited by 2 · see citing works
The role of impulsivity and impulse control disorders in the formation of addictive disorders
Dubatova, I. V., & Antsyborov, A. V. (2019) · Interactive science · doi:10.21661/r-497111 · Cited by 2 · see citing works
Crispo, J. A. G., Farhat, N., Fortin, Y., Perez‐Lloret, S., Sikora, L., Morgan, R. L., Habash, M., Gogna, P., Kelly, S., Elliott, J., et al. (2024) · Brain Sciences · doi:10.3390/brainsci14080776 · Cited by 1 · see citing works
Assessment of progression of Parkinson’s disease using magnetic resonance morphometry
Vlasova, I. A., Trufanov, A. G., Buriak, A. B., Kuznetsova, E. V., Odinak, M. M., & Litvinenko, I. (2022) · Russian neurological Journal · doi:10.30629/2658-7947-2022-27-4-37-43 · Cited by 1 · see citing works
Movement disorders in the elderly
Carr, J. A. (2013) · CME/Continuing medical education · Cited by 1 · see citing works
Crispo, J. A. G., Fortin, Y., Sikora, L., Kohen, D., Bjerre, L. M., Mattison, D. R., Perez‐Lloret, S., Hessian, R. C., Willis, A. W., & Krewski, D. R. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011843
UNCERTAINTY AND DECISION-MAKING IN THE HUMAN BRAIN
Vilares, I. (2013) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Neurogenetics and Epigenetics in Impulsive Behaviour: Impact on Reward
Oscar‐Berman, M., Blum, K., & Gold, M. S. (2012)
Polimorfismos genéticos na doênça de parkinson e perturbação no controlo de impulsos
Boleixa, D. (2014) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/7nnp-k843
Aarsland, D., Cummings, J. L., Weintraub, D., & Chaudhuri, К. R. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139856669.022
Possible Treatments of Atypical Parkinsonism
Moretti, D. V. (2016) · InTech eBooks · doi:10.5772/63948
Treatment of neuropsychiatric disturbances in Parkinson's disease: future prospects and strategies
Cummings, J. L., & Aarsland, D. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139856669.025
Neuropsiquiatría de los trastornos del movimiento
Orjuela-Rojas, J. M., Vincos, G. B., & Gallego, M. A. M. (2017) · Revista Colombiana de Psiquiatría · doi:10.1016/j.rcp.2017.05.010
de Almeida, B. L. C., Castro, B. M. D. A. E., & Grippe, T. C. (2019) · Programa de Iniciação Científica - PIC/UniCEUB - Relatórios de Pesquisa · doi:10.5102/pic.n1.2018.6411
Hypersexuality Due to Adverse Effects of Medicines and Surgical Interventions
Кочарян, Г. С. (2020) · Health of Man · doi:10.30841/2307-5090.2.2020.212914
PET and SPECT in Psychiatric Complications of Parkinson’s Disease
Kaasinen, V. (2020) · Springer eBooks · doi:10.1007/978-3-030-57231-0_8
Lawal, I., Vorster, M., Nyakale, N., & Sathekge, M. (2020) · PET and SPECT in Psychiatry · doi:10.1007/978-3-030-57231-0_24
Vorster, M., Nyakale, N. E., & Sathekge, M. M. (2014) · Springer eBooks · doi:10.1007/978-3-642-40384-2_25
de Almeida, B. L. C., Castro, B. M. D. A. E., & Grippe, T. C. (2021) · Programa de Iniciação Científica - PIC/UniCEUB - Relatórios de Pesquisa · doi:10.5102/pic.n0.2019.7654
نهج تكاملي لعلاج إدمان استهلاك المواد الإباحية
حريري, د. ه. ج. ب. (2024) · Journal of Arts, Literature, Humanities and Social Sciences · doi:10.33193/jalhss.99.2024.968
Addressing sexual difficulties in Parkinson's disease
Oprea, E. (2025) · Revue Neurologique · doi:10.1016/j.neurol.2025.10.004
PET and SPECT in Psychiatric Complications of Parkinson’s Disease
Kaasinen, V. (2014) · Springer eBooks · doi:10.1007/978-3-642-40384-2_10
Davydow, D. S., Purks, J. L., Jiang, S., Wong, J. K., Nolasco, D., Okun, M. S., Schiehser, D. M., Ferrara, D. L., Bowers, D., Vijayvargiya, R., et al. (2026) · Journal of the Academy of Consultation-Liaison Psychiatry · doi:10.1016/j.jaclp.2026.06.004
- Authors
- Vilas, D., Pont-Sunyer, C., & Tolosa, E.
- Affiliations
- Biomedical Research Networking Center on Neurodegenerative Diseases (ES)
- Corresponding author
- Tolosa, Eduardo
- Venue
- Parkinsonism & Related Disorders
- Publisher
- Elsevier BV
- Published
- 2012-01
- Volume
- 18
- Pages
- S80-S84
- ISSN
- 1353-8020 (ISSN-L)
- OpenAlex
- W2155446596
- Cited by
- 77
- References
- 31
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 4 · 2023: 1 · 2022: 4 · 2021: 4 · 2020: 6 · 2019: 4 · 2018: 2 · 2017: 2 · 2016: 5 · 2015: 10 · 2014: 14 · 2013: 14 · 2012: 4
- FWCI
- 6.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Parkinsonism & Related Disorders (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Social Sciences › Psychology › Clinical Psychology › Gambling Behavior and Treatments
- Health Sciences › Medicine › Neurology › Neurological disorders and treatments
- Keywords
- impulse control disorders, Parkinson's disease
- MeSH terms
- Animals, Compulsive Behavior, Humans, Disruptive, Impulse Control, and Conduct Disorders, Parkinson Disease, Risk Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
